The long term objectives are to elucidate the molecular mechanism of signal transduction in smooth muscle, from receptor activation to contraction and relaxation, and to use this information to explore the molecular and cellular mechanism of vascular abnormality (such as hypertension) and of the regulatory processes in other cell systems. Specifically, during the proposed Project Period, we wish to further elucidate the molecular mechanism of a novel signal transduction in smooth muscle: agonist-induced, G protein-mediated inhibition of myosin light chain (MLC) phosphatase to induce the Ca2+-sensitization of MLC phosphorylation and force. We shall (1) determine, using """"""""G protein- coupled"""""""", permeabilized smooth muscle in combination with two-dimensional gel electrophoresis, whether activation of PKC causes indirectly an activation of MLC kinase or an inhibition of the phosphatase or both to increase MLC phosphorylation and force in at a given Ca2+ concentration; (2) identify the in situ phosphorylation site(s) of MLC by PKC activation and GTPgammaS; (3) answer the question that diacylglycerol is the second messenger and resultant activation of PKC is involved in the G protein-- mediated Ca2+ sensitization. We shall further define the mechanism of G protein-mediated Ca2+-sensitization; (4) whether transient Ca2+- sensitization of MLC phosphorylation by GTPgammaS results from a re- activation of MLC phosphatase or a delayed inhibition of kinase activity; (5) to characterize the in situ MLC phosphatase regulated by G protein; (6) to examine the effects of ADP-ribosylating bacterial toxins and A1F4 to identify the type of G protein(s) responsible for the Ca2+ sensitization. We shall generalize the fact of G protein-mediated inhibition of smooth muscle MLC phosphatase; (7)to explore whether bidirectional modulation of protein phosphatase, not only inhibition but also activation, exists and has physiologically important role of cell functions and (8) to test the hypothesis that similar inhibition of protein phosphatase by G proteins has general functions in other cell systems.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL051824-03
Application #
2228786
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1993-06-01
Project End
1998-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Georgetown University
Department
Physiology
Type
Schools of Dentistry
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Kitazawa, Toshio (2010) G protein-mediated Ca²+-sensitization of CPI-17 phosphorylation in arterial smooth muscle. Biochem Biophys Res Commun 401:75-8
Woodsome, Terence P; Polzin, Atsuko; Kitazawa, Kazuyo et al. (2006) Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J Cell Sci 119:1769-80
Kitazawa, Toshio; Polzin, Atsuko N; Eto, Masumi (2004) CPI-17-deficient smooth muscle of chicken. J Physiol 557:515-28
Eto, Masumi; Kitazawa, Toshio; Brautigan, David L (2004) Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proc Natl Acad Sci U S A 101:8888-93
Kitazawa, Toshio; Eto, Masumi; Woodsome, Terence P et al. (2003) Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle. J Physiol 546:879-89
Eto, M; Kitazawa, T; Yazawa, M et al. (2001) Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J Biol Chem 276:29072-8
Woodsome, T P; Eto, M; Everett, A et al. (2001) Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol 535:553-64
Kitazawa, T; Eto, M; Woodsome, T P et al. (2000) Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275:9897-900
Kitazawa, T; Takizawa, N; Ikebe, M et al. (1999) Reconstitution of protein kinase C-induced contractile Ca2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle. J Physiol 520 Pt 1:139-52
Murahashi, T; Fujita, A; Kitazawa, T (1999) Ca2+ -induced Ca2+ desensitization of myosin light chain phosphorylation and contraction in phasic smooth muscle. Mol Cell Biochem 190:91-8

Showing the most recent 10 out of 14 publications